DNAPrint Genomics, Inc.
DNAG · OTC
12/31/2006 | 12/31/2005 | 12/31/2004 | 12/31/2003 | |
|---|---|---|---|---|
| Market Cap | $3 | $2 | $8 | $34 |
| - Cash | $1 | $2 | $1 | $0 |
| + Debt | $7 | $1 | $1 | $1 |
| Enterprise Value | $10 | $1 | $7 | $35 |
| Revenue | $2 | $1 | $1 | $1 |
| % Growth | 90.7% | 62.4% | 10.7% | – |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 31% | 25.5% | 35.3% | 39.1% |
| EBITDA | -$9 | -$2 | -$2 | -$5 |
| % Margin | -367% | -186.2% | -290.5% | -732% |
| Net Income | -$12 | -$9 | -$4 | -$8 |
| % Margin | -507.5% | -683.3% | -475.4% | -1,097.7% |
| EPS Diluted | -0.03 | -0.09 | -0.2 | -3.2 |
| % Growth | 66.7% | 55% | 93.8% | – |
| Operating Cash Flow | -$6 | -$4 | -$4 | -$2 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$6 | -$4 | -$4 | -$2 |